AptaBio Therapeutics Inc. (KOSDAQ: A293780)
Health Care · Biotechnology · KR
₩7,940.00
+1.79% today · -4.7% 1Y
AptaBio Therapeutics Inc. (KOSDAQ: A293780) operates in the Biotechnology industry within the Health Care sector. The company is valued at $165.92M.
Over the last twelve months the share price has lost 4.7%, trading between 3.87K and 10.89K.
Tweenvest scores AptaBio Therapeutics Inc. across four factors: quality 50/100, value 80/100. Its strongest factor is value.
A293780 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $165.92M
- Revenue (TTM)
- $3.07M
- P/E
- —
- EPS
- -540.42
- Dividend yield
- —
- Beta (5Y)
- 0.89
- 52-week high
- ₩10,890.00
- 52-week low
- ₩3,870.00
- Avg volume (3M)
- —
- Shares outstanding
- 28.09M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| HEM Pharma Inc.KOSDAQ: A376270 | $169.45M | ₩31,600.00 | -9.06% |
| Medigen Biotechnology Corp.TPEX: 3176 | $168.61M | NT$— | — |
| Canton Strategic Holdings, Inc.NasdaqCM: CNTN | $168.13M | $2.11 | 0.00% |
| Organogenesis Holdings Inc.NasdaqCM: ORGO | $165.99M | $1.25 | -3.10% |
| Coherus Oncology, Inc.NasdaqGM: CHRS | $165.32M | $1.04 | -3.27% |
| Burning Rock Biotech LimitedNasdaqGM: BNR | $163.36M | $15.30 | -1.23% |
| GC Cell CorporationKOSDAQ: A144510 | $163.20M | ₩14,600.00 | +0.14% |
| Protara Therapeutics, Inc.NasdaqGM: TARA | $162.81M | $2.78 | +0.91% |
Figures last refreshed Oct 11, 2026.